Methodology and development of a machine learning probability calculator: Data heterogeneity limits ability to predict recurrence after arthroscopic Bankart repair.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: The ML probability calculator is developed from pooled Bankart-repair literature with heterogeneity constraints and internally evaluated for recurrence; interpret as retrospective risk estimation. First publication date 2024-09-26 is corroborated by the primary bibliographic entry.
Technology: The ML probability calculator is developed from pooled Bankart-repair literature with heterogeneity constraints and internally evaluated for recurrence; interpret as retrospective risk estimation.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- The ML probability calculator is developed from pooled Bankart-repair literature with heterogeneity constraints and internally evaluated for recurrence; interpret as retrospective risk estimation.
- Limitation / still unknown
- The model was built from heterogeneous published cohorts and only internally evaluated; external prospective recurrence prediction was not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11948171/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.